SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is currently trending as its highly engaged community fervently champions the 'OG meme' narrative, positioning Rage Comics as a foundational 'meme reset' for the crypto market. Enthusiasts demonstrate strong conviction, actively developing an ecosystem with platforms like RageMaker and RageGames, while rallying others to 'Return to the Memes' and 'Rage On' to establish dominance in the sector. The community believes in the power of real cults behind original memes to move the entire market, advocating for consistency and building over fleeting trends.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is currently trending following a recent $75 million direct offering to a fundamental institutional investor, intended to fully fund its Phase 3 MASH trial preparation. This capital raise, coupled with Barclays initiating coverage with an 'Overweight' rating and a $20 price target, has fueled intense community discussion. Many are debating whether this strategic financing de-risks the company for a potential acquisition or partnership, leveraging its Breakthrough Therapy Designation for pemvidutide in the competitive MASH and weight loss market, despite some short-term concerns about dilution.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing a significant rally to new all-time highs, driven by growing community concerns over a weakening US dollar and increasing national debt, alongside broader geopolitical uncertainties. Investors are actively discussing a rotation into precious metals as a secure hedge, with many predicting substantial further gains while a minority cautiously eye a potential correction after the rapid ascent.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with knife ($CAW) is trending with its highly engaged community touting it as 'the only option' and highlighting its multichain expansion across platforms like Solana, Cronos, and Base. Discussions are buzzing around its deflationary burn mechanism and anticipated future developments, fueling bullish sentiment among its supporters.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending strongly following reports that China has approved the import of its H200 AI chips, a move seen by many as solidifying the company's leadership in the global AI hardware market. This development, alongside ongoing community discussions about its attractive valuation and the massive capital expenditure in AI infrastructure, is fueling widespread bullish sentiment and expectations for continued growth.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is currently trending as a critical beneficiary of the ongoing AI boom, fueled by record orders, strong guidance, and increased capital expenditures from major chipmakers like TSMC. The community is actively discussing its significant parabolic move, with debates around its valuation and potential for a stock split, while many highlight its indispensable technological monopoly in advanced semiconductor manufacturing.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as it surges to new all-time highs, ahead of the anticipated FOMC decision and a wave of major tech earnings reports. Bulls are celebrating the strong market momentum, while bears express caution, warning of a potential "blow off top" and market manipulation. The community is actively debating the sustainability of this rally amid a weakening dollar and surging precious metals.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as it relentlessly climbs to new all-time highs, primarily driven by strong momentum in mega-cap technology stocks ahead of pivotal earnings reports and an upcoming FOMC decision. Community sentiment is sharply divided, with many celebrating the 'infinity of money' pushing prices, while others warn of an 'overbought' and 'rigged' market, anticipating a potential 'bull trap' or significant pullback. The sustainability of this powerful tech-led rally remains a central point of contention among investors.

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics is trending following its announced collaboration with Microsoft's AI Co-Innovation Labs to integrate Azure-powered agentic AI into its ADAM robots. This news has sparked significant community discussion, with many anticipating substantial upside and a potential short squeeze, while others remain cautious about profit-taking and the long-term impact of the partnership.

Stride, Inc. is a technology-based educational company, which engages in the provision of proprietary and third-party curriculum, software systems and educational services. It also offers online curriculum and career services to middle and high school students, under the Destinations Career Academy brand name. The company was founded by Ronald J. Packard in 2000 and is headquartered in Reston, VA.

Stride Inc

Stride Inc. (LRN) is trending sharply following a significant earnings beat and robust enrollment growth, particularly in its career learning segment. The company's newly authorized $500 million stock repurchase program is fueling strong community discussion about its undervaluation and potential for a substantial short squeeze, especially given its recovery from prior market pressures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Sionna Therapeutics (NASDAQ:SION) Major Shareholder Sells 250,000 Shares of Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) major shareholder Tpg Gp A, Llc sold 250,000 shares of the stock in a transaction that occurred on Thursday, January 22nd. The shares were...

Tpg Gp A, Llc Sells 250,000 Shares of Sionna Therapeutics (NASDAQ:SION) Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) major shareholder Tpg Gp A, Llc sold 250,000 shares of the stock in a transaction dated Thursday, January 22nd. The shares were sold at an...

Sionna Therapeutics (NASDAQ:SION) Shares Gap Down - Here's Why

Sionna Therapeutics (NASDAQ:SION) Shares Gap Down - What's Next...

Sionna Therapeutics (NASDAQ:SION) Stock Price Up 8.1% - Here's Why

Sionna Therapeutics (NASDAQ:SION) Trading Up 8.1% - Here's What Happened...

Sionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 Shares

Key PointsSionna Therapeutics' Chief Legal Officer sold 10,250 shares for over $400k on Dec. 5, 2025...

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 10.1% - Here's What Happened

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 10.1% - Here's What Happened...

Sionna Therapeutics (NASDAQ:SION) Shares Down 7.5% - What's Next?

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 7.5% - Here's Why...

Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are presently covering the stock...

A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million

Key Points33,356 shares sold for a transaction value of $1,486,009.80 on Dec. 24, 2025...

Sionna Therapeutics (NASDAQ:SION) Director Peter Thompson Sells 33,356 Shares

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 33,356 shares of the firm's stock in a transaction dated Wednesday, December 24th. The shares were sold at an...

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

SION
Sionna Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SION News

SIONSionna Therapeutics Inc